Quadrant Biosciences to Offer Affordable Clarifi COVID-19 Testing to Businesses

Posted on September 15, 2021

SYRACUSE, NEW YORK, September 16, 2021 - Quadrant Biosciences Inc., a developer of molecular diagnostic tools, announced today that they will offer New York businesses with 100 or more employees affordable, weekly COVID testing to help meet new testing mandates that were announced by the federal government this week. 

The company’s Clarifi COVID-19 Test, developed in partnership with SUNY Upstate Medical University ("SUNY Upstate"), is a non-invasive, and easy to administer saliva swab test, and one of the few saliva tests to have received FDA emergency use authorization for pooled testing. Moreover, with a limit of detection (“LOD”) of as few as 600 copies of the SARS-CoV-2 virus per mL, the Clarifi COVID-19 test is the most sensitive saliva test currently on the market as referenced by the FDA.

The federal government recently announced that the Department of Labor’s Occupational Safety and Health Administration (OSHA) is developing a rule that will require all employers with 100 or more employees to ensure their workforce is fully vaccinated, or require any workers who remain unvaccinated to produce a weekly negative test result. 

To date, Quadrant’s Clarifi COVID-19 pooled testing program has been successfully adopted by numerous universities, K-12 schools, and government agencies. Recognizing that many private businesses across New York state, as well as the country, may need to quickly implement a testing program to satisfy this impending mandate, Quadrant is now offering its comprehensive and affordable testing solution to businesses. In addition to providing the test kits, the Clarifi COVID-19 testing program includes lab processing, result access via custom web app, training materials, and an account mentor to walk you through the onboarding process. 

The Clarifi COVID-19 Saliva Test is authorized for self-collection, so employers and employees can easily test on-site, with test results being delivered within 24-48 hours of samples arriving at Quadrant’s lab.  Employees, as well as designated “Organization Managers” for the company, will be able to quickly access results via an exclusive web app and make informed decisions should a positive case arise.

To learn more about COVID workplace testing, visit worksafe.quadrantbiosciences.com or request more information by completing a COVID request form

About Quadrant Biosciences

Quadrant Biosciences is a life science company developing molecular diagnostic solutions for large-scale health issues. The company has entered into collaborative research relationships with a number of institutions including SUNY Upstate Medical University and Penn State University to explore and develop novel biomarker technologies with a focus on Autism Spectrum Disorder, concussion, and Parkinson's disease. Recently, it has leveraged its expertise in RNA analysis to address the Covid-19 pandemic. Quadrant participates in the Start-up NY program, a New York State economic development program. For more information about Quadrant, please visit www.quadrantbiosciences.com.

The Clarifi COVID-19 Test Kit has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for use by authorized laboratories that are certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, and meet requirements to perform high-complexity tests. Clarifi COVID-19 has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Other Member News

Broadway in Syracuse
July 26, 2024

TICKETS FOR CAMERON MACKINTOSH’S ACCLAIMED PRODUCTION OF BOUBLIL AND SCHÖNBERG’S LES MISÉRABLES WILL GO ON SALE JULY 29TH AT 10AM

This reborn dream of a production looks and sounds fresher than ever. Sends shivers of excitement racing down the spine - You emerge feeling stirred and exhilarated.

Logo for Dannible & McKee, LLP
July 25, 2024

Dannible & McKee, LLP Announces the Promotion of 18 Professionals

The commitment to excellence from these 18 professionals is well demonstrated, and we congratulate them on their achievements.

Park Strategies Managing Director Featured in syracuse.com Article on New York's Cannabis Industry Rollout
July 24, 2024

Park Strategies Managing Director Featured in syracuse.com Article on New York's Cannabis Industry Rollout

His advocacy, born from an understanding of coalition-building and decision-making, has been influential amid many regulatory challenges.

Forbes Best Employers for Women logo
July 23, 2024

Excellus BlueCross BlueShield Recognized by Forbes as One of America’s Best Employers for Women 2024

This award highlights the organization’s ongoing commitment to fostering a diverse and inclusive workplace where women can thrive and advance their careers.

Ashley McGraw Architects
July 23, 2024

Ashley McGraw Architects Acquires studioMLA Architects, A National Leader in Early Education Design

Founded in 2006, studioMLA Architects is recognized as a national leader in the design of early education facilities along with nature-inspired playscapes for young children.

Mike Becallo
July 23, 2024

Michael Becallo Joins Oswego Health as Community Relations Representative

Originally from Cicero, Becallo is well-routed in CNY and brings over 15 years of healthcare experience.

Kate Weidman, Deputy Executive Director, AURORA of CNY
July 19, 2024

AURORA of CNY Announces Leadership Changes

Weidman will transition into the role of Executive Director following the retirement of current Executive Director Debra Chaiken, ensuring a seamless succession in leadership.

Credit Score 101
July 17, 2024

Credit Score 101 - Everything You Need to Know

Understanding and managing your credit score is a key step towards achieving financial stability and success. 

Larry Bousquet
July 16, 2024

Crouse Health Board of Directors Welcomes Two New Members

The Crouse Health Board of Directors has appointed two new directors.